OraSure Technologies Inc (OSUR)
4.24
+0.02
(+0.47%)
USD |
NASDAQ |
Jun 28, 16:00
4.255
+0.02
(+0.35%)
After-Hours: 20:00
OraSure Technologies SG&A Expense (Annual): 94.51M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 94.51M |
December 31, 2022 | 117.44M |
December 31, 2021 | 95.08M |
December 31, 2020 | 77.11M |
December 31, 2019 | 67.16M |
December 31, 2018 | 68.93M |
December 31, 2017 | 57.85M |
December 31, 2016 | 58.01M |
December 31, 2015 | 60.58M |
December 31, 2014 | 64.87M |
December 31, 2013 | 68.12M |
December 31, 2012 | 59.40M |
December 31, 2011 | 42.71M |
December 31, 2010 | 37.52M |
December 31, 2009 | 39.52M |
December 31, 2008 | 32.32M |
December 31, 2007 | 37.37M |
December 31, 2006 | 29.29M |
Date | Value |
---|---|
December 31, 2005 | 28.55M |
December 31, 2004 | 27.16M |
December 31, 2003 | 17.68M |
December 31, 2002 | 14.39M |
December 31, 2001 | 14.73M |
December 31, 2000 | 13.81M |
September 30, 1999 | 5.70M |
September 30, 1998 | 5.40M |
September 30, 1997 | 6.70M |
September 30, 1996 | 8.20M |
September 30, 1995 | 11.30M |
September 30, 1994 | 7.80M |
September 30, 1993 | 13.90M |
September 30, 1992 | 8.20M |
September 30, 1991 | 6.10M |
September 30, 1990 | 4.40M |
September 30, 1989 | 1.40M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
67.16M
Minimum
2019
117.44M
Maximum
2022
90.26M
Average
94.51M
Median
2023
SG&A Expense (Annual) Benchmarks
Integra Lifesciences Holdings Corp | 656.64M |
Insulet Corp | 734.90M |
Perspective Therapeutics Inc | 21.06M |
Xtant Medical Holdings Inc | 64.29M |
Asensus Surgical Inc | 36.08M |